JNJ-64457744
/ J&J
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
June 08, 2023
A Single and Multiple Ascending Dose Study of JNJ-64457744
(clinicaltrials.gov)
- P1 | N=60 | Terminated | Sponsor: Janssen Research & Development, LLC | N=135 ➔ 60 | Recruiting ➔ Terminated; Strategic business decision, not due to safety concerns
Enrollment change • Trial termination • Hepatitis B • Hepatology • Infectious Disease • Inflammation
August 15, 2022
A Single and Multiple Ascending Dose Study of JNJ-64457744
(clinicaltrials.gov)
- P1 | N=135 | Recruiting | Sponsor: Janssen Research & Development, LLC | Not yet recruiting ➔ Recruiting
Enrollment open • Hepatitis B • Hepatology • Infectious Disease • Inflammation
June 21, 2022
A Single and Multiple Ascending Dose Study of JNJ-64457744
(clinicaltrials.gov)
- P1 | N=135 | Not yet recruiting | Sponsor: Janssen Research & Development, LLC
New P1 trial • Hepatitis B • Hepatology • Infectious Disease • Inflammation
1 to 3
Of
3
Go to page
1